The biology of Hodgkin's lymphoma - PubMed (original) (raw)
Review
doi: 10.1038/nrc2542. Epub 2008 Dec 11.
Affiliations
- PMID: 19078975
- DOI: 10.1038/nrc2542
Review
The biology of Hodgkin's lymphoma
Ralf Küppers. Nat Rev Cancer. 2009 Jan.
Abstract
Hodgkin's lymphoma was first described in 1832. The aetiology of this lymphoma, however, remained enigmatic for a long time. Only within the past 10 years has the B-cell nature of the pathognomonic Hodgkin and Reed-Sternberg (HRS) cells been revealed, along with several recurrent genetic lesions. The pathogenetic role for Epstein-Barr virus infection has also been substantiated. HRS cells in classical Hodgkin's lymphoma have several characteristics that are unusual for lymphoid tumour cells, and the Hodgkin's lymphoma microenvironment is dominated by an extensive mixed, potentially inflammatory cellular infiltrate. Understanding the contribution of all of these changes to the pathogenesis of this disease is essential for the development of novel therapies.
Similar articles
- Molecular biology of Hodgkin lymphoma.
Küppers R. Küppers R. Hematology Am Soc Hematol Educ Program. 2009:491-6. doi: 10.1182/asheducation-2009.1.491. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008234 Review. - Hodgkin lymphoma.
Küppers R, Engert A, Hansmann ML. Küppers R, et al. J Clin Invest. 2012 Oct;122(10):3439-47. doi: 10.1172/JCI61245. Epub 2012 Oct 1. J Clin Invest. 2012. PMID: 23023715 Free PMC article. Review. - Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M, Wei W, Nagy E, Prouzova Z, Schrader A, Kube D, Rowe M, Woodman CB, Murray PG. Vockerodt M, et al. J Pathol. 2013 Aug;230(4):399-409. doi: 10.1002/path.4198. J Pathol. 2013. PMID: 23592216 - Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.
Carbone A, Gloghini A, Larocca LM, Antinori A, Falini B, Tirelli U, Dalla-Favera R, Gaidano G. Carbone A, et al. Blood. 1999 Apr 1;93(7):2319-26. Blood. 1999. PMID: 10090942
Cited by
- Deciphering the Genetic Complexity of Classical Hodgkin Lymphoma: Insights and Effective Strategies.
Lee C, An Y. Lee C, et al. Curr Genomics. 2024;25(5):334-342. doi: 10.2174/0113892029301904240513045755. Epub 2024 May 24. Curr Genomics. 2024. PMID: 39323623 Free PMC article. Review. - Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.
Pan Y, Cengiz R, Kluiver J, Diepstra A, Van den Berg A. Pan Y, et al. Cancers (Basel). 2024 Mar 12;16(6):1126. doi: 10.3390/cancers16061126. Cancers (Basel). 2024. PMID: 38539461 Free PMC article. Review. - Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan.
Kawasaki A, Hatake K, Matsumura I, Izutsu K, Hoshino T, Akamatsu A, Kakuuchi A, Tobinai K. Kawasaki A, et al. Int J Hematol. 2024 Jun;119(6):667-676. doi: 10.1007/s12185-024-03734-y. Epub 2024 Mar 23. Int J Hematol. 2024. PMID: 38521840 Free PMC article. - Management of limited-stage Hodgkin lymphoma.
Al-Juhaishi T, Ahmed S. Al-Juhaishi T, et al. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):500-509. doi: 10.1182/hematology.2023000511. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066938 - Potential Associations between Vascular Biology and Hodgkin's Lymphoma: An Overview.
Rodrigues WF, Miguel CB, Abreu MCM, Neto JM, Oliveira CJF. Rodrigues WF, et al. Cancers (Basel). 2023 Nov 6;15(21):5299. doi: 10.3390/cancers15215299. Cancers (Basel). 2023. PMID: 37958472 Free PMC article. Review.
References
- Blood. 2008 Jan 1;111(1):292-301 - PubMed
- N Engl J Med. 1999 Apr 22;340(16):1239-47 - PubMed
- Am J Pathol. 1995 Oct;147(4):912-22 - PubMed
- Blood. 2005 Dec 15;106(13):4249-52 - PubMed
- Cancer Res. 2001 Mar 1;61(5):2080-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous